Full Name
Andrew Michael Lindsay Lever
(not current staff)
Variants
Andrew M L Lever
 
Main Affiliation
 
 
Email
mdcamll@nus.edu.sg
 

Publications

Results 1-20 of 46 (Search time: 0.022 seconds).

Issue DateTitleAuthor(s)
120082008 Nobel prize in Medicine for discoverers of HIVLever, A.M.L ; Berkhout, B
22017A highly reproducible quantitative viral outgrowth assay for the measurement of the replication-competent latent HIV-1 reservoirFun, A; Mok, H.P; Wills, M.R; Lever, A.M 
32006A method to estimate the efficiency of gene expression from an integrated retroviral vectorMok, H.P; Lever, A 
42018A new method for detecting signal regions in ordered sequences of real numbers, and application to viral genomic dataGog J.R.; Lever A.M.L. ; Skittrall J.P.
52015A novel combined RNA-protein interaction analysis distinguishes HIV-1 Gag protein binding sites from structural change in the viral RNA leaderKenyon, J.C ; Prestwood, L.J; Lever, A.M.L 
62019A novel, sensitive dual-indicator cell line for detection and quantification of inducible, replication-competent latent HIV-1 from reservoir cellsSalasc, F.; Gludish, D.W.; Jarvis, I.; Boliar, S.; Wills, M.R.; Russell, D.G.; Lever, A.M.L. ; Mok, H.-P.
72019A scale-free analysis of the HIV-1 genome demonstrates multiple conserved regions of structural and functional importanceSkittrall, J.P.; Ingemarsdotter, C.K.; Gog, J.R.; Lever, A.M.L. 
82018An RNA-binding compound that stabilizes the HIV-1 gRNA packaging signal structure and specifically blocks HIV-1 RNA encapsidationIngemarsdotter, C.K; Zeng, J; Long, Z; Lever, A.M.L ; Kenyon, J.C 
92005Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interactionGrainger, D.J; Lever, A.M.L 
102018CD32-expressing CD4 T cells are phenotypically diverse and can contain proviral HIV DNAMartin, G.E; Pace, M; Thornhill, J.P; Phetsouphanh, C; Meyerowitz, J; Gossez, M; Brown, H; Olejniczak, N; Lwanga, J; Ramjee, G; Kaleebu, P; Porter, K; Willberg, C.B; Klenerman, P; Nwokolo, N; Fox, J; Fidler, S; Frater, J; Lever, A ; Wills, M; Weber, J; Dorrell, L; Malim, M; Gupta, R; Jolly, C; On Behalf of the CHERUB Investigato
112016Coordination of genomic RNA packaging with viral assembly in HIV-1Hellmund, C; Lever, A.M.L 
122014Current perspectives on RNA secondary structure probingKenyon, J ; Prestwood, L; Lever, A 
132020DDX5 potentiates HIV-1 transcription as a co-factor of TatSithole, N.; Williams, C.A.; Abbink, T.E.M.; Lever, A.M.L. 
142007Dimerisation of HIV-2 genomic RNA is linked to efficient RNA packaging, normal particle maturation and viral infectivityL'Hernault, A; Greatorex, J.S; Crowther, R.A; Lever, A.M.L 
152016Disrupted Endothelial Cell Layer and Exposed Extracellular Matrix Proteins Promote Capture of Late Outgrowth Endothelial Progenitor CellsZhao, J; Mitrofan, C.-G; Appleby, S.L; Morrell, N.W; Lever, A.M.L 
1620-Sep-2021Duplex formation between the template and the nascent strand in the transcription-regulating sequences is associated with the site of template switching in SARS–CoV-2Aaron R D’Souza ; Amanda B Buckingham; Fanny Salasc; Carin K Ingemarsdotter; Gennaro Iaconis; Isobel Jarvis; Harriet Groom; Julia C Kenyon ; Andrew M L Lever 
173-Oct-2021EAP45 association with budding HIV-1: Kinetics and domain requirementsMeng, Bo; Vallejo Ramirez, P.P.; Scherer, Katharina M.; Bruggeman, Ezra; Kenyon, Julia C. ; Kaminski, Clemens F.; Lever, Andrew M. 
182015Evidence that the endosomal sorting complex required for transport-II (ESCRT-II) is required for efficient human immunodeficiency virus-1 (HIV-1) productionMeng, B; Ip, N.C.Y; Prestwood, L.J; Abbink, T.E.M; Lever, A.M.L 
192013Experimental Pathways towards Developing a Rotavirus Reverse Genetics System: Synthetic Full Length Rotavirus ssRNAs Are Neither Infectious nor Translated in Permissive CellsRichards J.E.; Desselberger U.; Lever A.M. 
202008Herpes simplex 1 encephalitis presenting as a brain haemorrhage with normal cerebrospinal fluid analysis: A case reportGkrania-Klotsas, E; Lever, A.M.L